24 completed, 17 unknown, 16 recruiting, 8 active not recruiting. 24 Not applicable, 16 Phase 2, 15 Early Phase 1, 11 Phase 1, 4 Phase 4.
Follow 18F-FDG: new trials by email Literature Review of 18F-FDG trials Research Report on 18F-FDG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity 68Ga-Galmydar, PET/MRI, 18F-FDG - Lymphoma Cancer, Breast Cancer | Phase 1 | Not yet recruiting | Washington University School of Medicine | 36 | 2026-11-01 | 2026-09-24 |
| Multi-organ Imaging of Microvascular and Metabolic Function 18F-FDG, Positron Emission Tomography (PET) - Healthy Subjects (HS), Cardiovascular Diseases (CVD) | Early Phase 1 | Not yet recruiting | Massachusetts General Hospital | 60 | 2026-07-01 | 2026-05-22 |
| Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution 18F-FDG, Breast-dedicated PET camera - Breast Cancer | Early Phase 1 | Withdrawn | Stanford University | 2026-06-01 | 2026-05-29 | |
| 5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors 18F-FDG, 68Ga-MY - Lung Cancer, Breast Cancer | Not applicable | Not yet recruiting | Peking University Cancer Hospital & Institute | 20 | 2026-06-01 | 2026-05-15 |
| Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET 18F-FAPI-74, 18F-FDG, PET/CT - Breast Cancer, Metastatic Invasive Lobular Breast Cancer | Phase 2 | Not yet recruiting | Randy Yeh | 15 | 2026-06-01 | 2026-05-01 |
| Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma 18F-FDG - Urothelial Carcinoma | Not applicable | Recruiting | Peking University Cancer Hospital & Institute | 20 | 2026-05-31 | 2026-03-04 |
| Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes 18F-FDG, [18F]F-PDL1-3 - Lung Cancer (NSCLC), Cervical Squamous Cell Cancer | Phase 2 | Recruiting | Peking University Cancer Hospital & Institute | 50 | 2026-02-01 | 2026-09-29 |
| PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors 89Zr-LNCab104, 89Zr-LNCab103, 18F-FDG - Breast Cancer, Gastric Cancer (GC) | Early Phase 1 | Enrolling by invitation | Affiliated Hospital of Jiangnan University | 10 | 2025-07-01 | 2025-06-17 |
| The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies 18F-FDG, 89Zr-LNCab190, 89Zr-LNCab002 - Breast Cancer, Gastric Cancer (GC) | Early Phase 1 | Enrolling by invitation | Affiliated Hospital of Jiangnan University | 20 | 2025-07-01 | 2025-06-17 |
| Ultralow Dose PET Imaging of 18F-FDG Uptake 18F-FDG - Healthy Volunteer, Cancer | Phase 2 | Recruiting | Akiva Mintz | 200 | 2025-05-12 | 2025-06-04 |
| NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease 18F-DPA-714, 18F-FDG - Positron Emission Tomography | Early Phase 1 | Recruiting | University of California, Davis | 12 | 2025-04-30 | 2026-08-18 |
| A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma 18F-FDG, 68Ga-BC1 - Multiple Myeloma and Malignant Plasma Cell Neoplasms | Early Phase 1 | Recruiting | Peking University First Hospital | 50 | 2025-04-15 | 2025-06-06 |
| Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients 68Ga-FAPI-04, 18F-FDG - Breast Cancer | Not applicable | Completed | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 27 | 2025-04-01 | 2026-04-28 |
| Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73 68Ga-dPNE, 18F-FDG - Malignant Tumour | Early Phase 1 | Completed | First Affiliated Hospital of Fujian Medical University | 15 | 2025-03-01 | 2026-10-21 |
| Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3 18F-FDG, 18F-FDG PET/CT - Granulomatosis With Polyangiitis (Wegener's) | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 31 | 2025-01-01 | 2026-07-17 | |
| CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors 18F-FDG - Solid Tumor | Not yet recruiting | Peking University Cancer Hospital & Institute | 30 | 2025-01-01 | 2024-12-27 | |
| Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging 18F-FDG, [68Ga]Ga-TTP - Breast Cancer | Not applicable | Recruiting | Peking University Cancer Hospital & Institute | 60 | 2024-12-10 | 2026-08-11 |
| CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors 18F-FDG - Solid Tumor | Recruiting | Hua Zhu | 30 | 2024-12-01 | 2024-12-05 | |
| Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization 18F-FDG - Solid Tumor | Not applicable | Recruiting | Hua Zhu | 50 | 2024-08-20 | 2024-08-22 |
| Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors 18F-FDG - Solid Tumor | Not applicable | Unknown | Peking University Cancer Hospital & Institute | 20 | 2024-05-01 | 2023-11-29 |
Showing 20 of 78. Sign in to see all of them.
Breast Neoplasms (14) · Lung Neoplasms (7) · Neoplasms (5) · Carcinoma, Renal Cell (4) · Carcinoma, Transitional Cell (4) · Disease (4) · Prostatic Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (3) · Cardiovascular Diseases (3) · Melanoma (3) · Multiple Myeloma (3) · Neuroendocrine Tumors (3) · Stomach Neoplasms (3) · Uterine Cervical Neoplasms (3) · Brain Neoplasms (2)
Peking University Cancer Hospital & Institute (9) · Peking Union Medical College Hospital (7) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (4) · Affiliated Hospital of Jiangnan University (3) · Hua Zhu (3) · Jonsson Comprehensive Cancer Center (3) · Peking University First Hospital (3) · Stanford University (3) · University of California, Davis (3) · Washington University School of Medicine (3) · Chang Gung Memorial Hospital (2) · Copenhagen University Hospital, Rigshospitalet (2) · First Affiliated Hospital of Fujian Medical University (2) · National Cancer Institute (NCI) (2) · University of Edinburgh (2)
China (37) · United States (25) · United Kingdom (4) · Denmark (2) · Taiwan (2) · Canada (1) · India (1) · Netherlands (1) · Norway (1)
Hua Zhu (5) · Zhaohui Zhu, MD (3) · Andreas Kjaer, MD (2) · Guobao Wang, PhD (2) · Jeremie Calais, MD (2) · Marc R Dweck, MD PhD (2) · Peter L Choyke, M.D. (2) · Weibing Miao, MD (2) · Xiaoli Lan, PhD (2) · Zhaohui Zhu, MD,PHD (2) · Adrienne H Brouwers, MD PhD (1) · Albert Koong (1) · Andrei M Iagaru, MD (1) · Bradley Kemp, PhD (1)
PMID 19487962, PMID 21617977, PMID 22326218, PMID 24764034, PMID 25783515, PMID 26703796, PMID 27153497, PMID 27236466, PMID 27607176, PMID 27659017, PMID 27683031, PMID 27690345, PMID 27710970, PMID 27729297, PMID 32826320, PMID 33531464, PMID 33568190, PMID 34677626, PMID 34746970, PMID 36512649, PMID 36600099, PMID 37191681, PMID 38176719, PMID 38748286, PMID 39353648, PMID 41101974, PMID 42378054, PMID 42489707
2017 (1), P30CA022453 (1), P30CA124435 (1), R01CA195450 (1), R01EB033435 (1), R01HL180913 (1), R61AT012187 (1), U01CA079778 (1), U01CA080098 (1), U24CA220325 (1)